AASLD-Summary of current and future Hepatitis C investigational inhibitors and Interferon-free regimens

Summary Of The American Association for the Study of Liver Diseases November 2011 Annual Meeting

This AASLD Summary attempts to present recent data in an accessible format providing a greater understanding of current and future gentler HCV therapies that could be available in the near future.

Included are many of the investigational second-generation protease inhibitors and Interferon-free treatment regimens presented at this months meeting.